Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2021 - 2024)
Centessa Pharmaceuticals (CNTA) reported Depreciation and Depletion of $48000.0 for Q4 2024, down 47.83% year-over-year from $92000.0 in Q1 2024, and down 41.46% quarter-over-quarter from $82000.0 in Q3 2024.
Centessa Pharmaceuticals (CNTA) Depreciation and Depletion (2021 - 2024) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 4 years of Depreciation and Depletion data on file, last reported at $48000.0 in Q4 2024.
- Depreciation and Depletion for Q4 2024 came in at $48000.0, down 47.83% year-over-year; the trailing twelve-month figure through Dec 2024 was $300000.0 (changed 0.0% YoY), and the FY2025 annual result was $300000.0, changed 0.0% from the prior year.
- Depreciation and Depletion declined to $48000.0 in Q4 2024 per CNTA's latest filing, from $82000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $92000.0 in Q4 2023 and troughed at $5434.0 in Q2 2021.
- A 4-year average of $53727.0 and a median of $42500.0 in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion surged 488.88% in 2022, then plunged 47.83% in 2024.
- A 4-year view of Depreciation and Depletion shows it stood at $15744.0 in 2021, then soared by 128.66% to $36000.0 in 2022, then soared by 155.56% to $92000.0 in 2023, then sank by 47.83% to $48000.0 in 2024.
- Business Quant data shows CNTA's Depreciation and Depletion at $48000.0 in Q4 2024, $82000.0 in Q3 2024, and $84000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 87,000.00 |
| Sep 30, 2023 | 87,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Sep 30, 2022 | 35,000.00 |